Phage therapy: beyond antibacterial action
Andrzej Górski , Ewa Jończyk-Matysiak , Ryszard Międzybrodzki , Beata Weber-Dąbrowska , Marzanna Łusiak-Szelachowska , Natalia Bagińska , Jan Borysowski , Małgorzata B. Łobocka , Alicja Węgrzyn , Grzegorz Węgrzyn
AbstractUntil recently, phages were considered as mere “bacteria eaters” with potential for use in combating antimicrobial resistance. The real value of phage therapy assessed according to the standards of evidence-based medicine awaits confirmation by clinical trials. However, the progress in research on phage biology has shed more light on the significance of phages. Accumulating data indicate that phages may also interact with eukaryotic cells. How such interactions could be translated into advances in medicine (especially novel means of therapy) is discussed herein.
|Journal series||Frontiers in Medicine, ISSN , e-ISSN 2296-858X, (0 pkt)|
|Publication size in sheets||1.2|
|Keywords in English||phage, phage therapy, immunomodulation, inflammation, prophage induction|
|License||Journal (articles only); published final; ; with publication|
|Score||= 5.0, 29-11-2019, ArticleFromJournal|
|Publication indicators||= 6; = 4|
|Citation count*||10 (2019-12-01)|
* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.